Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Dosage
1 evidence topic · 2 sources
Ulixacaltamide
Essential tremor
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted by February 2026
- Launch
- Not announced
- Last updated